title: Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern?
authors.forename: A D
authors.initials: AD
authors.lastname: Ormerod
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D003879:Dermatologic Agents / Q000009:adverse effects*; D004195:Disease Models, Animal; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D009369:Neoplasms / Q000139:chemically induced*; D016559:Tacrolimus / Q000009:adverse effects* / Q000031:analogs & derivatives*
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; C117268:pimecrolimus; D016559:Tacrolimus